These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26906088)

  • 1. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
    Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
    J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
    Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
    Rheumatology (Oxford); 2024 Sep; 63(9):2363-2371. PubMed ID: 38479813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
    Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses.
    Angeli F; Pedretti E; Garrafa E; Fredi M; Ceribelli A; Franceschini F; Cavazzana I
    Diagnostics (Basel); 2024 Sep; 14(19):. PubMed ID: 39410596
    [No Abstract]   [Full Text] [Related]  

  • 5. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
    Yamasaki Y; Kobayashi N; Akioka S; Yamazaki K; Takezaki S; Nakaseko H; Ohara A; Nishimura K; Nishida Y; Sato S; Kishi T; Hashimoto M; Mori M; Okazaki Y; Kuwana M; Ohta A
    Rheumatology (Oxford); 2021 Oct; 60(10):4821-4831. PubMed ID: 33576399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population.
    Loganathan A; McMorrow F; Lu H; Li D; Mulhearn B; McHugh NJ; Tansley SL
    Front Immunol; 2022; 13():975939. PubMed ID: 36177007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies.
    Hamaguchi Y; Kuwana M; Takehara K
    Clin Rheumatol; 2020 Nov; 39(11):3489-3497. PubMed ID: 32385758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.
    Mahler M; Betteridge Z; Bentow C; Richards M; Seaman A; Chinoy H; McHugh N
    Front Immunol; 2019; 10():848. PubMed ID: 31114570
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.
    Tansley SL; Li D; Betteridge ZE; McHugh NJ
    Rheumatology (Oxford); 2020 Aug; 59(8):2109-2114. PubMed ID: 32030410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.
    Wang L; Huang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Luo H; Zuo X; Li Y; Xiao X; Zhang H
    Clin Rheumatol; 2018 Oct; 37(10):2731-2739. PubMed ID: 30039266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
    Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
    Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.
    Mammen AL; Casciola-Rosen L; Christopher-Stine L; Lloyd TE; Wagner KR
    Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e172. PubMed ID: 26668818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
    Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
    Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.